{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T19:49:26Z","timestamp":1785268166605,"version":"3.55.0"},"reference-count":22,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,2,7]],"date-time":"2023-02-07T00:00:00Z","timestamp":1675728000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec><jats:title>Purpose<\/jats:title><jats:p>The helmet is a novel interface for delivering non-invasive ventilation (NIV). We conducted a case series to characterize introduction of the helmet interface in both COVID and non-COVID patients at two-centres.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We enrolled all patients with respiratory failure admitted to the Juravinski Hospital (Hamilton, Canada) and St. Joseph\u2019s Health Center (Syracuse, New York) between November 1, 2020 and June 30, 2021 who used the helmet interface (Intersurgical StarMed) as part of this introduction into clinical practice. We collected patient demographics, reason for respiratory failure, NIV settings, device-related complications and outcomes. We report respiratory therapist\u2019s initial experiences with the helmet using descriptive results.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>We included 16 patients with a mean age of 64.3\u2009\u00b1\u200910.9\u2009years. The most common etiology for respiratory failure was pneumonia (81.3%). The median duration of NIV during the ICU admission was 67.5 (15.3, 80.8) hours, with a mean maximum PS of 13.9\u2009\u00b1\u20096.6\u2009cm H2O and a mean maximum PEEP of 10.4\u2009\u00b1\u20095.1\u2009cm H20. Three patients (18.7%) did not tolerate the helmet. Ten (62.5%) patients ultimately required intubation, and 7 (43.4%) patients died while in the ICU. The most common reason for intubation was worsening hypoxia (70%). No adverse events related to the helmet were recorded.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Over the 8-month period of this study, we found that the helmet was well tolerated in over 80% of patients, although, more than half ultimately required intubation. Randomized controlled trials with this device are required to fully assess the efficacy of this interface.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fmed.2023.1075797","type":"journal-article","created":{"date-parts":[[2023,2,7]],"date-time":"2023-02-07T07:13:54Z","timestamp":1675754034000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Introducing helmet non-invasive ventilation during COVID-19 pandemic: Early experience of two centres"],"prefix":"10.3389","volume":"10","author":[{"given":"Dipayan","family":"Chaudhuri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rishi","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen E. A.","family":"Burns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua","family":"Piticaru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah J.","family":"Cook","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bram","family":"Rochwerg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,2,7]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/S0140-6736(09)60496-7","article-title":"Non-invasive ventilation in acute respiratory failure","volume":"374","author":"Nava","year":"2009","journal-title":"Lancet"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1001\/jama.2022.0028","article-title":"Effect of noninvasive respiratory strategies on intubation or mortality among patients with acute hypoxemic respiratory failure and COVID-19: The RECOVERY-RS randomized clinical trial","volume":"327","author":"Perkins","year":"2022","journal-title":"JAMA"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"1602426","DOI":"10.1183\/13993003.02426-2016","article-title":"Official ERS\/ATS clinical practice guidelines: noninvasive ventilation for acute respiratory failure","volume":"50","author":"Rochwerg","year":"2017","journal-title":"Eur Respir J"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"2435","DOI":"10.1001\/jama.2016.6338","article-title":"Effect of noninvasive ventilation delivered by helmet vs face mask on the rate of endotracheal intubation in patients with acute respiratory distress syndrome a randomized clinical trial","volume":"315","author":"Patel","year":"2016","journal-title":"JAMA"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/S2213-2600(14)70267-X","article-title":"Life behind the mask: the patient experience of NIV","volume":"3","author":"Smith","year":"2015","journal-title":"Lancet Respir Med"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1001\/jama.293.5.589","article-title":"Continuous positive airway pressure for treatment of postoperative hypoxemia: a randomized controlled trial","volume":"293","author":"Squadrone","year":"2005","journal-title":"JAMA"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1164\/rccm.202008-3070OC","article-title":"Quantitative assessment of viral dispersion associated with respiratory support devices in a simulated critical care environment","volume":"203","author":"Avari","year":"2021","journal-title":"Am J Respir Crit Care Med"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1378\/chest.14-1934","article-title":"Exhaled air dispersion during noninvasive ventilation via helmets and a total facemask","volume":"147","author":"Hui","year":"2015","journal-title":"Chest"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1007\/s00134-014-3325-5","article-title":"Helmet CPAP vs. oxygen therapy in severe hypoxemic respiratory failure due to pneumonia","volume":"40","author":"Brambilla","year":"2014","journal-title":"Intensive Care Med"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1378\/chest.09-2290","article-title":"Helmet continuous positive airway pressure vs oxygen therapy to improve oxygenation in community-acquired pneumonia: a randomized, controlled trial","volume":"138","author":"Cosentini","year":"2010","journal-title":"Chest"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1001\/jama.2021.4682","article-title":"Effect of helmet noninvasive ventilation vs high-flow nasal oxygen on days free of respiratory support in patients with COVID-19 and moderate to severe hypoxemic respiratory failure","volume":"325","author":"Grieco","year":"2021","journal-title":"JAMA"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1001\/jama.2020.9524","article-title":"Association of noninvasive oxygenation strategies with all-cause mortality in adults with acute hypoxemic respiratory failure: a systematic review and meta-analysis","volume":"324","author":"Ferreyro","year":"2020","journal-title":"JAMA"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"2101269","DOI":"10.1183\/13993003.01269-2021","article-title":"Helmet non-invasive ventilation compared to facemask non-invasive ventilation and high flow nasal cannula in acute respiratory failure: a systematic review and meta-analysis","volume":"59","author":"Chaudhuri","year":"2021","journal-title":"Eur Respir J"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"2575","DOI":"10.1053\/j.jvca.2020.04.060","article-title":"Role of helmet-delivered noninvasive pressure support ventilation in COVID-19 patients","volume":"34","author":"Ing","year":"2020","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1016\/j.ijsu.2014.07.013","article-title":"The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies","author":"von Elm","year":"2014","journal-title":"Int J Surg"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1007\/s00134-008-1120-x","article-title":"Helmet ventilation and carbon dioxide rebreathing: effects of adding a leak at the helmet ports","volume":"34","author":"Racca","year":"2008","journal-title":"Intensive Care Med"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1097\/00000542-200401000-00007","article-title":"Noninvasive positive pressure ventilation using a helmet in patients with acute exacerbation of chronic obstructive pulmonary disease","volume":"100","author":"Antonelli","year":"2004","journal-title":"Anesthesiology"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1164\/ajrccm.160.5.9903015","article-title":"Acute respiratory failure in patients with severe community-acquired pneumonia: a prospective randomized evaluation of noninvasive ventilation","author":"Confalonieri","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/cc13103","article-title":"Brun-Buisson C. non-invasive ventilation for acute hypoxemic respiratory failure: intubation rate and risk factors","volume":"17","author":"Thille","year":"2013","journal-title":"Crit Care"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"ofaa421","DOI":"10.1093\/ofid\/ofaa421","article-title":"Prolonged low-dose methylprednisolone in patients with severe COVID-19 pneumonia","author":"Salton","year":"2020","journal-title":"Open Forum Infect Dis"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1056\/NEJMoa2021436","article-title":"Dexamethasone in hospitalized patients with Covid-19","volume":"384","year":"2021","journal-title":"N Engl J Med"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1513\/AnnalsATS.202007-805OC","article-title":"Comparison of clinical features and outcomes in critically ill patients hospitalized with COVID-19 versus influenza","volume":"18","author":"Cobb","year":"2021","journal-title":"Ann Am Thorac Soc"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2023.1075797\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,7]],"date-time":"2023-02-07T07:13:57Z","timestamp":1675754037000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2023.1075797\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,7]]},"references-count":22,"alternative-id":["10.3389\/fmed.2023.1075797"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2023.1075797","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,7]]},"article-number":"1075797"}}